Establishment and 12-month progress of the New Zealand Motor Neurone Disease Registry.

ResearchSpace/Manakin Repository

Show simple item record

dc.contributor.author Walker, Kerry L en
dc.contributor.author Rodrigues, Miriam en
dc.contributor.author Watson, Beth en
dc.contributor.author Reilly, Claire en
dc.contributor.author Scotter, Emma en
dc.contributor.author Brunton, Heather en
dc.contributor.author Turnbull, Janet en
dc.contributor.author Roxburgh, Richard en
dc.date.accessioned 2020-02-13T03:41:02Z en
dc.date.issued 2019-02 en
dc.identifier.issn 0967-5868 en
dc.identifier.uri http://hdl.handle.net/2292/49998 en
dc.description.abstract There are only limited treatments currently available for Motor Neurone Disease, each with modest benefits. However, there is a large amount of research and drug discovery currently underway worldwide. The New Zealand Motor Neurone Disease Registry was established in 2017 to facilitate participation in research and clinical trials, and to aid researchers in planning and recruitment. The NZ MND Registry is an opt in patient registry which collects demographic, contact and clinical data for those who choose to enrol. We report anonymised aggregated data from the first year's enrolment. 12th July 2018, there were 142 participants enrolled in the NZ MND Registry. Participant sex distribution reflects the demographics reported worldwide, but ethnicity is divergent from what is seen in New Zealand overall, with an over-representation of people who identify as New Zealand European. 85.5% of participants are diagnosed with sporadic MND and 6.1% with familial MND. The remainder were participants who have not been diagnosed but have a family history, or positive genetic test for a MND-causing mutation. Levels of disability are reported using ALSFRS-R scores, and show that the majority of participants are within the higher range of the scale. The registry has facilitated entry of patients into three studies to date. The establishment of the NZ MND Registry illustrates a swift launch of a rare disease patient registry. The role of patient registries is an ever changing one, but with clear utility at every point of along the pathway to drug discovery. en
dc.format.medium Print-Electronic en
dc.language eng en
dc.relation.ispartofseries Journal of Clinical Neuroscience en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.subject Humans en
dc.subject Motor Neuron Disease en
dc.subject Registries en
dc.subject Middle Aged en
dc.subject New Zealand en
dc.subject Female en
dc.subject Male en
dc.title Establishment and 12-month progress of the New Zealand Motor Neurone Disease Registry. en
dc.type Journal Article en
dc.identifier.doi 10.1016/j.jocn.2018.11.034 en
pubs.begin-page 7 en
pubs.volume 60 en
dc.rights.holder Copyright: The author en
pubs.end-page 11 en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Review en
pubs.subtype Journal Article en
pubs.elements-id 757184 en
pubs.org-id Medical and Health Sciences en
pubs.org-id School of Medicine en
pubs.org-id Medicine Department en
pubs.org-id Science en
pubs.org-id Biological Sciences en
dc.identifier.eissn 1532-2653 en
pubs.record-created-at-source-date 2018-11-27 en
pubs.dimensions-id 30473407 en


Full text options

Full text for this item is not available in ResearchSpace.

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Advanced Search

Browse